Orange Book product
VELETRI EQ 0.5MG BASE/VIAL
Orange Book NDA 022260 · ACTELION PHARMACEUTICALS US INC · Prescription
Key facts
| Proprietary name | VELETRI |
|---|---|
| Active ingredients | EPOPROSTENOL SODIUM |
| Strength | EQ 0.5MG BASE/VIAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Application | NDA022260 |
| Applicant holder | ACTELION PHARMACEUTICALS US INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AP2 |
| Reference listed drug (RLD) | Yes |
| Reference standard (RS) | No |
| Approval date | Jun 28, 2012 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- Yes Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.